KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Shares Issued: 2009-2024

Historic Shares Issued for Arbutus Biopharma (ABUS) over the last 16 years, with Dec 2024 value amounting to $7.5 million.

  • Arbutus Biopharma's Shares Issued fell 50.06% to $794,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year decrease of 11.43%. This contributed to the annual value of $7.5 million for FY2024, which is 1297.57% up from last year.
  • As of FY2024, Arbutus Biopharma's Shares Issued stood at $7.5 million, which was up 1,297.57% from $535,000 recorded in FY2023.
  • Arbutus Biopharma's 5-year Shares Issued high stood at $86.3 million for FY2020, and its period low was $395,000 during FY2022.
  • Its 3-year average for Shares Issued is $2.8 million, with a median of $535,000 in 2023.
  • In the last 5 years, Arbutus Biopharma's Shares Issued plummeted by 97.55% in 2021 and then skyrocketed by 1,297.57% in 2024.
  • Over the past 5 years, Arbutus Biopharma's Shares Issued (Yearly) stood at $86.3 million in 2020, then crashed by 97.55% to $2.1 million in 2021, then plummeted by 81.28% to $395,000 in 2022, then spiked by 35.44% to $535,000 in 2023, then skyrocketed by 1,297.57% to $7.5 million in 2024.